Form 4: Zentalis Pharmaceuticals Insider Buys Shares
Insider Transaction (Form 4)
Walters Group and 2 others reported changes in beneficial ownership of Zentalis Pharmaceuticals, Inc. common stock on August 14, 2026.
Summary
- Open-market purchase: acquired 4,335,000 Common Stock at $3.50 ($15,172,500) on August 14, 2026; holds 17,844,973 after (Direct).
Sentiment
Score: 9
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $15,172,500, committing personal capital to the stock.
Insider Transactions
Walters Group — 10% owner
William Thurman Walters — 10% owner
Susan Berkley Walters — 10% owner
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-14 | Open-market purchase | Common Stock | 4,335,000 | $4 | $15.2M | 17,844,973 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-14 | Open-market purchase (4,335,000 shares) |
Keywords
insider transaction, Form 4, ZNTL, Zentalis Pharmaceuticals, Inc., bullish, Walters Group, William Thurman Walters, Susan Berkley Walters
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.